Antares Therapeutics, Inc. — Form D
Antares Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-12. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-12
- Form: D
- Accession: 0002059043-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $40.0M
- Investors: 3
- Date of first sale: 2025-03-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-540681
Issuer
- Name: Antares Therapeutics, Inc.
- CIK: 0002059043
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: ONE WINTHROP SQUARE, SUITE 400, BOSTON, MA, 02110
- Phone: 781-288-5760
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Andrew Fedder | Director | Boston, MA |
| Brian Piper | Director | Boston, MA |
| Shelley Chu | Director | Lexington, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Andrew Fedder | Executive Officer | Boston, MA |
| Menelas N Pangalos | Director | Boston, MA |
| Jeffrey Albers | Director | Boston, MA |
| Keith Flaherty | Director | Boston, MA |
| Adam Friedman | Director | Boston, MA |
| Adam Friedman | Executive Officer | Boston, MA |
| Brian Piper | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More